The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Heart rate: Activity mismatch as a prognostic marker of survival in metastatic non-small cell lung cancer (NSCLC).
 
Sonam Puri
Consulting or Advisory Role - AstraZeneca (Inst); G1 Therapeutics (Inst)
 
Yeonjung Jo
No Relationships to Disclose
 
Benjamin Haaland
No Relationships to Disclose
 
Kathleen Claire Kerrigan
Stock and Other Ownership Interests - bristol myers squibb (I)
Travel, Accommodations, Expenses - Flatiron Health
 
Shiven B. Patel
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Tersera; Total Health Conferencing
Research Funding - AstraZeneca (Inst); Merck (Inst); Takeda (Inst)
 
Adriana M Coletta
No Relationships to Disclose
 
Kelly Moynahan
No Relationships to Disclose
 
Laura Cannon
No Relationships to Disclose
 
Matthew Gumbleton
Patents, Royalties, Other Intellectual Property - US patent number US20170151262A1 pending--SHIP inhibition to induce activation of natural killer cells. (Inst)
 
Nicole Hillman
No Relationships to Disclose
 
Kelsey Embrey
No Relationships to Disclose
 
Wallace L. Akerley
Consulting or Advisory Role - Calithera Biosciences
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Loxo (Inst)
Other Relationship - Lilly